Omeros corporation

Major-Pharmaceuticals

OMER


201 Elliott Avenue West
Seattle , WA 98119

Executive/
Director

Price

  • Last Close
  • $ 11.63
    $ +0.55 4.92 %
    Dec 6, 2024
  • 52-Week High/Low
  • $5.4 - $1.08
  • YTD
  • 255.7%

  • Trading Volume
  • 33,682
  • Market Cap Full
  • $ 731.1M
  • Shares Outstanding
  • 62.9M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -11.1% -2.5% 52.4% -42.5% 55.9% -5% 24.6% -6.5% 105.8% 5.5%
Q2 -18.3% -31.4% 31.7% 68.1% -9.7% 4% -16.6% -54.2% 17% -4.4%
Q3 -39.1% 6.1% 8.6% 31.9% 3% 8% -7.3% 14.6% -46.3% -
Q4 43.5% -11.1% -13% -20.2% -11.1% 41.3% -53.3% -28.3% 18.1% -
J F M A M J J A S O N D
2024 -0.9% 38.9% -23.3% -11.6% - - - - - - - -
2023 28.3% 30% 23.3% 24.7% 6.9% -12.3% -20% -20.5% -15.6% -59.3% 84% 49.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    119%-37%-37%96%-43%28%0%-55%-65%45%256%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.43 0.42 0.24 -0.62 -0.5 -0.53 -0.57 -0.53 -0.54
Q2 0.37 0.24 0.23 -0.7 -0.29 -0.61 -0.46 -0.49 -0.59
Q3 0.46 0.26 0.07 -0.81 -0.33 -0.66 -0.36 -0.28 -0.60
Q4 0.45 0.20 0.25 -0.48 -0.59 -0.61 4.51 2.06 -
A 1.7 1.1 0.8 -2.6 -1.7 -2.4 3.1 0.8 -1.73

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 49 54.2 61.9 62.7 62.8
Jun 48.3 49.1 54.5 62.3 62.7 62.8
Sep 48.6 49.3 54.5 62.5 62.7 62.9
Dec 49 49.7 61.7 62.5 62.7 62.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - 1 1 -
Fixed Asset Turnover - - 14.8 18.7 5
Total Asset Turnover - - 0.4 0.8 0.3
Leverage
Debt Ratio 0.5 1.3 1.6 1.5 1.7
Debt – Equity Ratio 2.6 13 -2 -1.5 -1.5
Interest Coverage 0.8 0.5 -4.1 -3 -7.5
Equity multiplier 1.5 6 - -0.1 -0.1